Skip to Main Content

Paper Details

Disulfide High-Mobility Group Box 1 Drives Ischemia-Reperfusion Injury in Human Liver Transplantation.
Hepatology
35
2021
Disulfide, HMGB1, High-Mobility Group Box 1, Human, IRI, Ischemia-Reperfusion Injury, Portal, Sterile inflammation, Toll-like receptor 4, disulfide, disulfide-, high-mobility group box 1, histone acetyltransferase, histone deacetylase 5, human, ischemia-reperfusion injury, liver IRI, lysosomal disulfide-HMGB1, macrophages, myocardial infarction, patient, patients, sterile inflammation, stroke, transcription factor IIIC subunit, tumor necrosis factor alpha
Author NameAffiliation
Maura RossettiDepartment of Pathology and Laboratory MedicineDavid Geffen School of Medicine at university of california los angelesLos AngelesCA.
Maura RossettiDepartment of Pathology and Laboratory MedicineDavid Geffen School of Medicine at university of california los angelesLos AngelesCA.
Bita V NainiDepartment of Pathology and Laboratory MedicineDavid Geffen School of Medicine at university of california los angelesLos AngelesCA.
Bita V NainiDepartment of Pathology and Laboratory MedicineDavid Geffen School of Medicine at university of california los angelesLos AngelesCA.
Victoria GroysbergDepartment of Pathology and Laboratory MedicineDavid Geffen School of Medicine at university of california los angelesLos AngelesCA.
Ali ZarrinparDumont-university of california los angeles Transplantation CenterDepartment of SurgeryDavid Geffen School of Medicine at university of california los angelesLos AngelesCA.
Elaine F ReedDepartment of Pathology and Laboratory MedicineDavid Geffen School of Medicine at university of california los angelesLos AngelesCA.
Elaine F ReedDepartment of Pathology and Laboratory MedicineDavid Geffen School of Medicine at university of california los angelesLos AngelesCA.
  • 1 - 8

Datasets

Release 1.2